This report highlights additional challenges of type 2 pleuropulmonary blastoma and early second cancer in a child, suggesting the need for vigilant follow-up.
Pleuropulmonary Blastoma (PPB) presents unique challenges due to its rarity, diverse clinical behaviors, and association with germline DICER1 mutations, emphasizing the need for advanced diagnostics and multidisciplinary management. This case describes the atypical presentation of type 2 PPB, the early development of a second cancer, and the need for vigilance to ensure optimal patient outcomes. We report a 5-year-old boy with type 2 PPB, previously managed for Wilms’ tumor who developed bilateral coin lesions discovered in the lungs during the follow-up, requiring surgical resection with histological confirmation of type 2 PPB. He was treated with IVADo regimen (ifosfamide, vincristine, actinomycin D, and doxorubicin) and is currently on follow-up. The early development and recognition of a rare second cancer with diverse clinical behaviors are dependent on focused surveillance post-treatment.
No takes yet. Share an insight, caveat, or question.
Damola-Okesiji et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: